Biocryst receives US FDA approval for human test of influenza drug
Monday, December 26, 2005 09:00 IST Birmingham
BioCryst Pharmaceuticals has received from the US Food and Drug Administration a verbal approval to begin studies with intravenous peramivir, the company's influenza neuraminidase inhibitor.